Note 21 - Segment Information: Schedule of Segment Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating income (loss)	$ (414,979)	$ (309,547)	$ (856,578)	$ (1,452,127)
Interest income	24,968	21,541	65,504	87,006
Interest expense	8,513	6,080	22,697	16,455
Cannabis and Medical Marijuana Segment
Net revenue	11,730	13,312	36,297	145,564
Operating income (loss)	4,516	(38,426)	(16,624)	(734,818)
Interest income	8	30	0	19,745
Interest expense	0	0	0	0
Property additions	0	0	0	0
Depreciation and amortization	0	0	0	0
Total assets			2,095,569	2,661,427
Facility Operations Related
Net revenue	1,219,800	1,058,025	3,503,563	3,031,519
Operating income (loss)	(230,490)	9,276	(174,878)	67,162
Interest income	0	4	0	10
Interest expense	9,517	7,214	25,829	19,857
Property additions	6,490	0	23,231	8,159
Depreciation and amortization	3,892	2,653	10,190	7,959
Total assets			1,955,675	1,662,764
Corporate and Eliminations
Net revenue	0	0	0	0
Operating income (loss)	(189,005)	(280,397)	(665,076)	(784,471)
Interest income	24,960	21,507	65,504	67,251
Interest expense	(1,004)	(1,134)	(3,132)	(3,402)
Property additions	2,581	0	7,593	0
Depreciation and amortization	2,038	2,932	4,679	8,796
Total assets			702,561	945,089
Consolidated
Net revenue	1,231,530	1,071,337	3,539,860	3,177,083
Operating income (loss)	(414,979)	(309,547)	(856,578)	(1,452,127)
Interest income	24,968	21,541	65,504	87,006
Interest expense	8,513	6,080	22,697	16,455
Property additions	9,071	0	30,824	8,159
Depreciation and amortization	$ 5,930	$ 5,585	14,869	16,755
Total assets			$ 4,753,805	$ 5,269,280